For clinical applications, wearable or implantable MF generators are being developed to facilitate localized and patient-specific neuromodulation (Davidson et al., 2024
(PubMed) Smith AD, Refsum H, Bottiglieri T, et al
Its a repair and recovery peptide and is probably being used in some orthopedic practices, where its injected into injuries and joints that have failed to recover from complex injuries or surgeries, she says
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
B12 improves your overall health, which only intensifies the results of the Lipo-B12 injections
